{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:42:43Z","timestamp":1771015363179,"version":"3.50.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>Yolk sac tumor of the endometrium is an uncommon neoplasm. Here we report a case of yolk sac tumor arising in a uterine carcinosarcoma, with the carcinomatous component showing both endometrioid and serous components, and the sarcomatous component showing homologous (spindled) differentiation. The yolk sac tumor showed predominant glandular configuration and was present admixed with the epithelial components. Extensive immunostaining was performed to narrow the differential diagnosis, including potentially therapeutic testing for HER-2. To our knowledge, this is the first case of carcinosarcoma with this mix of epithelial components and corresponding reporting of these immune and therapeutic markers.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000774","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T13:21:01Z","timestamp":1616764861000},"page":"40-44","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Yolk Sac Tumor Arising in Uterine Carcinosarcoma With Endometrioid and Serous Components: A Case Report With Immunohistochemical Analysis"],"prefix":"10.1097","volume":"41","author":[{"given":"Samuel","family":"Grindstaff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda C.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Banet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,24]]},"reference":[{"key":"R1-20250802","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0000000000000722","article-title":"Yolk sac tumor in extragonadal pelvic sites: still a diagnostic challenge","volume":"1","author":"Ravishankar","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R2-20250802","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/s41379-019-0341-6","article-title":"Endometrial tumors with yolk sac tumor-like morphologic patterns or immunophenotypes: an expanded appraisal","volume":"32","author":"Fadare","year":"2019","journal-title":"Mod Pathol"},{"key":"R3-20250802","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2006.04.024","article-title":"Primary yolk sac tumor concomitant with carcinosarcoma originating from the endometrium: case report","volume":"103","author":"Oguri","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R4-20250802","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00404-019-05309-3","article-title":"Primary yolk sac tumor of the endometrium: a case report and review of the literatures","volume":"300","author":"Lu","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"R5-20250802","first-page":"647","article-title":"Malignant mullerian mixed tumor of the uterus with a prominent alpha-fetoprotein-producing component of yolk sac tumor","volume":"9","author":"Shokeir","year":"1996","journal-title":"Mod Pathol"},{"key":"R6-20250802","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update","volume":"36","author":"Wolff","year":"2018","journal-title":"J Clin Oncol"},{"key":"R7-20250802","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.ejso.2006.07.010","article-title":"Yolk sac tumours of the ovary: an update","volume":"32","author":"D\u00e4llenbach","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"R8-20250802","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejogrb.2009.02.052","article-title":"Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors","volume":"146","author":"Cicin","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R9-20250802","first-page":"6713","article-title":"Malignant ovarian germ cell tumors in postmenopausal patients: The Royal Marsden Experience and Literature Review","volume":"35","author":"Boussios","year":"2015","journal-title":"Anticancer Res"},{"key":"R10-20250802","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00004347-199904000-00007","article-title":"HER-2\/neu amplification and overexpression in endometrial carcinoma","volume":"18","author":"Rolitsky","year":"1999","journal-title":"Int J Gynecol Pathol"},{"key":"R11-20250802","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/modpathol.2013.113","article-title":"Toward standard HER2 testing of endometrial serous carcinoma: 4-year experience at a large academic center and recommendations for clinical practice","volume":"26","author":"Buza","year":"2013","journal-title":"Mod Pathol"},{"key":"R12-20250802","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/PAS.0000000000000182","article-title":"HER2 immunohistochemistry significantly overestimates HER2 amplification in uterine papillary serous carcinomas","volume":"38","author":"Mentrikoski","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R13-20250802","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1200\/JCO.2017.76.5966","article-title":"Randomized phase II trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-trastuzumab in uterine serous carcinomas that overexpress human epidermal growth factor receptor 2\/neu","volume":"36","author":"Fader","year":"2018","journal-title":"J Clin Oncol"},{"key":"R14-20250802","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41379-019-0358-x","article-title":"HER2 testing of gynecologic carcinosarcomas: tumor stratification for potential targeted therapy","volume":"33","author":"Rottmann","year":"2020","journal-title":"Mod Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:02:19Z","timestamp":1754161339000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,24]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000774","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,24]]}}}